Literature DB >> 11604520

CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain.

H Poulsen1, J Nilsson, C K Damgaard, J Egebjerg, J Kjems.   

Abstract

RNA editing of specific residues by adenosine deamination is a nuclear process catalyzed by adenosine deaminases acting on RNA (ADAR). Different promoters in the ADAR1 gene give rise to two forms of the protein: a constitutive promoter expresses a transcript encoding (c)ADAR1, and an interferon-induced promoter expresses a transcript encoding an N-terminally extended form, (i)ADAR1. Here we show that (c)ADAR1 is primarily nuclear whereas (i)ADAR1 encompasses a functional nuclear export signal in the N-terminal part and is a nucleocytoplasmic shuttle protein. Mutation of the nuclear export signal or treatment with the CRM1-specific drug leptomycin B induces nuclear accumulation of (i)ADAR1 fused to the green fluorescent protein and increases the nuclear editing activity. In concurrence, CRM1 and RanGTP interact specifically with the (i)ADAR1 nuclear export signal to form a tripartite export complex in vitro. Furthermore, our data imply that nuclear import of (i)ADAR1 is mediated by at least two nuclear localization sequences. These results suggest that the nuclear editing activity of (i)ADAR1 is modulated by nuclear export.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604520      PMCID: PMC99958          DOI: 10.1128/MCB.21.22.7862-7871.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Identification of different roles for RanGDP and RanGTP in nuclear protein import.

Authors:  D Görlich; N Panté; U Kutay; U Aebi; F R Bischoff
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

2.  Characterization of the nuclear protein import mechanism using Ran mutants with altered nucleotide binding specificities.

Authors:  K Weis; C Dingwall; A I Lamond
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

3.  Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase.

Authors:  Y Liu; C X George; J B Patterson; C E Samuel
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

4.  Analysis of Xenopus dsRNA adenosine deaminase cDNAs reveals similarities to DNA methyltransferases.

Authors:  R F Hough; B L Bass
Journal:  RNA       Date:  1997-04       Impact factor: 4.942

5.  Deamination of mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deaminase: similarities to in vivo RNA editing.

Authors:  S R Hurst; R F Hough; P J Aruscavage; B L Bass
Journal:  RNA       Date:  1995-12       Impact factor: 4.942

6.  A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway.

Authors:  W M Michael; M Choi; G Dreyfuss
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

7.  Purification of human double-stranded RNA-specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA.

Authors:  M A O'Connell; A Gerber; W Keller
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

8.  Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase.

Authors:  S Maas; T Melcher; A Herb; P H Seeburg; W Keller; S Krause; M Higuchi; M A O'Connell
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

9.  Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins.

Authors:  M Rexach; G Blobel
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

10.  Editing of the GLuR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase.

Authors:  G A Dabiri; F Lai; R A Drakas; K Nishikura
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

View more
  70 in total

Review 1.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm.

Authors:  Swee Kee Wong; Shuji Sato; David W Lazinski
Journal:  RNA       Date:  2003-05       Impact factor: 4.942

3.  Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain.

Authors:  Alexander Strehblow; Martina Hallegger; Michael F Jantsch
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

4.  A role for Z-DNA binding in vaccinia virus pathogenesis.

Authors:  Yang-Gyun Kim; Maneesha Muralinath; Teresa Brandt; Matthew Pearcy; Kevin Hauns; Ky Lowenhaupt; Bertram L Jacobs; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

Review 5.  Activity regulation of adenosine deaminases acting on RNA (ADARs).

Authors:  Cesare Orlandi; Alessandro Barbon; Sergio Barlati
Journal:  Mol Neurobiol       Date:  2011-11-20       Impact factor: 5.590

Review 6.  Substitutional A-to-I RNA editing.

Authors:  Bjorn-Erik Wulff; Kazuko Nishikura
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Jul-Aug       Impact factor: 9.957

7.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 8.  Current strategies for Site-Directed RNA Editing using ADARs.

Authors:  Maria Fernanda Montiel-Gonzalez; Juan Felipe Diaz Quiroz; Joshua J C Rosenthal
Journal:  Methods       Date:  2018-11-29       Impact factor: 3.608

Review 9.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 10.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.